NEWS #Sun Pharma
Compliance review: US FDA issues 8 observations for Sun Pharma’s Halol plant following GMP inspection
Discover the key details and implications of the recent compliance review involving Sun Pharma’s Halol facility, as the US FDA issues eight observations following a detailed GMP inspection, shedding light on regulatory requirements and the pharmaceutical industry's quality standards. Read more:https://www.hrpf.us/webinars/fda-inspections-top-fda-483-observations-and-prevention-strategies